Key Players involved in the Retinal Biologics Market are Johnson & Johnson Services, Inc. (US), Ocular Therapeutixc. (US), Hoffmann-La Roche Ltd (Basel, Switzerland), Regeneron Pharmaceuticals Inc. (US), AbbVie Inc. (US), Amgen Inc. (US), Spark Therapeutics (US) and MeiraGTx Limited (US). Key Players involved in the Retinal Biologics Market are Johnson & Johnson Services, Inc. (US), Ocular Therapeutixc. (US), Hoffmann-La Roche Ltd (Basel, Switzerland), Regeneron Pharmaceuticals Inc. (US), AbbVie Inc. (US), Amgen Inc. (US), Spark Therapeutics (US) and MeiraGTx Limited (US).

By A Silva